Gene · 3623
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon. | BMC Microbiol | 2025 | 40059193 | PubTator, text mining | PubMed |
| Synthesis, DFT study, in silico ADMET evaluation, molecular docking, and QSAR analysis of new anti-tuberculosis drugs derived from 2-hydroxybenzohydrazide derivatives. | Mol Divers | 2025 | 40021588 | PubTator, text mining | PubMed |
| Repurposing of apoptotic inducer drugs against Mycobacterium tuberculosis. | Sci Rep | 2025 | 40016256 | PubTator, text mining | PubMed |
| Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling. | Nat Commun | 2025 | 40011426 | PubTator, text mining | PubMed |
| Identification of DNA Methylation Differences in Pituitary Tissues of Sichuan White Geese Using Whole-Genome Bisulfite Sequencing (WGBS). | Biology (Basel) | 2025 | 40001922 | PubTator, text mining | PubMed |
| Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. | Antimicrob Agents Chemother | 2025 | 39918315 | PubTator, text mining | PubMed |
| Molecular docking, ADME properties and synthesis of thiophene sulfonamide derivatives. | Drug Chem Toxicol | 2025 | 39538963 | PubTator, text mining | PubMed |
| In silico molecular characterization of TGF-β gene family in Bufo bufo: genome-wide analysis. | J Biomol Struct Dyn | 2025 | 38345010 | PubTator, text mining | PubMed |
| NR5A1/SF-1 Collaborates with Inhibin α and the Androgen Receptor. | Int J Mol Sci | 2024 | 39337600 | PubTator, text mining | PubMed |
| Microenvironment of spermatogonial stem cells: a key factor in the regulation of spermatogenesis. | Stem Cell Res Ther | 2024 | 39256786 | PubTator, text mining | PubMed |
| Rare Sequence Variation Underlying Suspected Familial Cerebral Small-Vessel Disease. | J Am Heart Assoc | 2024 | 39082428 | PubTator, text mining | PubMed |
| Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma. | Sci Rep | 2024 | 39075165 | PubTator, text mining | PubMed |
| Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh. | Indian J Tuberc | 2024 | 39067960 | PubTator, text mining | PubMed |
| Synthesis of indole-functionalized isoniazid conjugates with potent antimycobacterial and antioxidant efficacy. | Future Med Chem | 2024 | 39041719 | PubTator, text mining | PubMed |
| Design, synthesis, and anti-mycobacterial evaluation of 1,8-naphthyridine-3-carbonitrile analogues. | RSC Adv | 2024 | 39027042 | PubTator, text mining | PubMed |
| Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti-Mycobacterium tuberculosis agents targeting enoyl acyl carrier protein reductase (InhA). | RSC Adv | 2024 | 38984262 | PubTator, text mining | PubMed |
| Polymerase Chain Reaction (PCR) Profiling of Extensively Drug-Resistant (XDR) Pathogenic Bacteria in Pulmonary Tuberculosis Patients. | Cureus | 2024 | 38953074 | PubTator, text mining | PubMed |
| The Hidden Epidemic of Isoniazid-Resistant Tuberculosis in South Africa. | Ann Am Thorac Soc | 2024 | 38935769 | PubTator, text mining | PubMed |
| Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study. | Medicine (Baltimore) | 2024 | 38847724 | PubTator, text mining | PubMed |
Dual-centre evaluation of the FluoroType MTBDR version 2 assay for detection of Mycobacterium tuberculosis complex and resistance-conferring mutations in pulmonary and extrapulmonary samples from Denmark, Germany and Sierra Leone. | Clin Microbiol Infect | 2024 | 38621623 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3623/papers?page=4